Intensity-Modulated Proton Therapy Market Statistics, Trends, and Key Players by 2031

MARKET INTRODUCTION

Intensity-modulated proton therapy (IMPT) is the electromagnetic spatial control of well-circumscribed "pencil beams" of protons of variable energy and intensity. Proton pencil beams take advantage of the charged-particle Bragg peak-the characteristic peak of dose at the end of the range-combined with the modulation of pencil beam variables to create target-local modulations in the dose that achieves the dose objectives. IMPT improves on X-ray intensity-modulated beams (intensity-modulated radiotherapy or volumetric modulated arc therapy) with dose modulation along the beam axis as well as lateral, in-field, dose modulation. The clinical practice of IMPT further improves the healthy tissue vs. target dose differential in comparison with X-rays and thus allows increased target dose with dose reduction elsewhere.

MARKET DYNAMICS

The intensity-modulated proton therapymarket has shown a significant evolution over the forecast period.The growth of the intensity-modulated proton therapymarket is majorly driven by the rise in cancer patients' prevalence, growing awareness among people, improvement in insurance coverage for proton therapy, increase in consumption of tobacco, and surge in demand for proton therapy. According to the WHO, cancer is a leading cause of death worldwide, and cancer deaths are expected to continue to rise to over 13.1 million by 2031.Excessive tobacco use is associated with an increased risk of several cancers, including lung, oral cavity, pharynx, bladder, esophagus, kidney, liver, stomach, larynx, pancreas, bowel, cervix, leukemia, and ovarian. According to the World Health Organization, in 2015, over 1.1 billion people smoked tobacco, and the number continues to rise. Moreover, technological advancements and an increase in health care expenditure are the other factors fueling the growth of the intensity-modulated proton therapymarket. However, the high treatment cost is a major restraint of the intensity-modulated proton therapymarket.

MARKET SCOPE

The "Intensity- Modulated Proton TherapyMarket Analysis to 2031" is a specialized and in-depth study of themedical device in the healthcare industry, with a specific focus on the global market trend analysis. This report provides an outline of the intensity-modulated proton therapymarket with detailed market segmentation by product, application, and end-user. The intensity-modulated proton therapymarket isestimated to witness high growth during the forecast period. It focuses on the vital statistics on the leading players' market status in the intensity-modulated proton therapymarket and offers key opportunities and trends in the market.

MARKET SEGMENTATION

The market is categorized based onthe product, application, and end user. Based on the product, the market is segmented as synchrotron type, cyclotron type, synchronous cyclotron type, linear accelerator type. Based on the application,the segmentationof the market is into breast cancer, brain cancer, prostrate cancer, others. Basedon end user,segmentation of the market is intohospitals, proton treatment centers,and others.

REGIONAL FRAMEWORK

The report states a detailed outline of the industry, consisting of both qualitative and quantitative information. It gives a sketch and forecast of the intensity-modulated proton therapymarket based onvarious segments.
The report also consists of market size and forecast estimates from the year 2021 to2031with respect to five primary regions, namely; North America, Asia-Pacific (APAC), Europe, Middle East, and Africa (MEA), and South & Central America (SCAM). The intensity-modulated proton therapymarket by each region is then subdivided into respective countries and segments. It offers the analysis and forecast of 18 countriesworldwide and the recent trend and opportunities prevailing in the region.

The report analyzes factors affecting the intensity-modulated proton therapymarket from both the demand and supply sides. Furthermore, it assesses market dynamics affecting the market during the forecast period, i.e., drivers, restraints, opportunities, and future trends. It also comprises a precise PEST analysis for all five regions, namely, North America, APAC,Europe, MEA, and South & Central America, after evaluating political, social, economic,and technological factors affecting the intensity-modulated proton therapy market in these regions.

MARKET PLAYERS

The report contains critical developments in the intensity-modulated proton therapymarket as inorganic and organic growth strategies. Various companies are pivoting on organic growth strategies like product approvals, product launches, and others, such as events and patents. Inorganic growth strategies noticed in the market were acquisitions and collaborations &partnerships. Such activities have paved the path for the expansion of the business and customer base of market players. The market players from the intensity-modulated proton therapymarket are anticipated to have profitable growth opportunities in the following years with the increasing demand for intensity-modulated proton therapy in the global market. Below mentioned is the list of a few companies engaged in the intensity-modulated proton therapymarket.

The report also offers key players' profiles in the intensity-modulated proton therapy market, along with their SWOT analysis and market strategies. Also, the report focuses on leading market players with information on company profiles, financial information of the last three years, components, and services provided,critical development in the past five years.

•  Varian Medical Systems, Inc.
  
•  Sumitomo Heavy Industries, Ltd.
  
•  Provision Healthcare ((ProNova)
  
•  Ion Beam Applications S.A. (IBA)
  
•  Hitachi, Ltd.
  
•  Mevion Medical Systems
  
•  ProTom International.
  
•  Mitsubishi Electric Corporation
  

The Insight Partner's dedicated research and analysis team comprises of experienced professionals with advanced statistical expertise and offers various customization options in the current study.

Intensity-Modulated Proton Therapy Report Scope